Reuters logo
BRIEF-Fennec announces preliminary results of SIOPEL 6 study on PEDMARK to be presented at SIOP meeting
September 13, 2017 / 4:32 PM / 13 days ago

BRIEF-Fennec announces preliminary results of SIOPEL 6 study on PEDMARK to be presented at SIOP meeting

Sept 13 (Reuters) - Fennec Pharmaceuticals Inc

* Fennec announces preliminary results of SIOPEL 6 study on PEDMARK(sodium thiosulfate) to be presented at the 49th Congress of the International Society Of Pediatric Oncology (SIOP) 2017 meeting

* Says ‍SIOPEL 6 shows that addition of sodium thiosulfate significantly reduces incidence of cisplatin-induced hearing loss

* Says ‍combination of cis+sts was generally well tolerated​

* Says ‍randomised phase III trial shows addition of sodium thiosulfate significantly reduces incidence of cisplatin-induced hearing loss​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below